nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—CHRM5—Signaling Pathways—HDAC1—ocular cancer	0.00075	0.00075	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MAML2—ocular cancer	0.000738	0.000738	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—GNA11—ocular cancer	0.00073	0.00073	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MAML2—ocular cancer	0.000727	0.000727	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MAML2—ocular cancer	0.000725	0.000725	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MAML2—ocular cancer	0.000723	0.000723	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MAML2—ocular cancer	0.00072	0.00072	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HDAC1—ocular cancer	0.000715	0.000715	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MAML2—ocular cancer	0.000713	0.000713	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CDKN2B—ocular cancer	0.000712	0.000712	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MAML2—ocular cancer	0.000711	0.000711	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HDAC1—ocular cancer	0.000706	0.000706	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CDKN2B—ocular cancer	0.000702	0.000702	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—GNA11—ocular cancer	0.000699	0.000699	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GNAQ—ocular cancer	0.000699	0.000699	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—GNAQ—ocular cancer	0.000679	0.000679	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CDKN2B—ocular cancer	0.000673	0.000673	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—E2F1—ocular cancer	0.000654	0.000654	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—GNAQ—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—E2F1—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—GNA11—ocular cancer	0.000644	0.000644	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CDKN2B—ocular cancer	0.000641	0.000641	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—GNA11—ocular cancer	0.000634	0.000634	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—GNA11—ocular cancer	0.000633	0.000633	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CDKN2B—ocular cancer	0.000632	0.000632	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—GNA11—ocular cancer	0.000631	0.000631	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—GNA11—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—GNA11—ocular cancer	0.000622	0.000622	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—GNA11—ocular cancer	0.000621	0.000621	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—E2F1—ocular cancer	0.000617	0.000617	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HDAC1—ocular cancer	0.000612	0.000612	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—GNAQ—ocular cancer	0.000599	0.000599	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—GNAQ—ocular cancer	0.000589	0.000589	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—E2F1—ocular cancer	0.000588	0.000588	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—GNAQ—ocular cancer	0.000588	0.000588	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—GNAQ—ocular cancer	0.000586	0.000586	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HDAC1—ocular cancer	0.000586	0.000586	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—GNAQ—ocular cancer	0.000584	0.000584	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—E2F1—ocular cancer	0.000581	0.000581	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—GNAQ—ocular cancer	0.000579	0.000579	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—GNAQ—ocular cancer	0.000577	0.000577	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CDKN2B—ocular cancer	0.000548	0.000548	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HDAC1—ocular cancer	0.00054	0.00054	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HDAC1—ocular cancer	0.000531	0.000531	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HDAC1—ocular cancer	0.00053	0.00053	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HDAC1—ocular cancer	0.000528	0.000528	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HDAC1—ocular cancer	0.000527	0.000527	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CDKN2B—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HDAC1—ocular cancer	0.000522	0.000522	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	0.00052	0.00052	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—E2F1—ocular cancer	0.000503	0.000503	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CDKN2B—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000474	0.000474	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CDKN2B—ocular cancer	0.000472	0.000472	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	0.000468	0.000468	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000466	0.000466	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000444	0.000444	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000437	0.000437	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—E2F1—ocular cancer	0.000436	0.000436	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—E2F1—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—E2F1—ocular cancer	0.000433	0.000433	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—E2F1—ocular cancer	0.000429	0.000429	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000428	0.000428	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MDM2—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MDM2—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MDM2—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HRAS—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HRAS—ocular cancer	0.000362	0.000362	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CDKN1B—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—AKT1—ocular cancer	0.000357	0.000357	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CDKN1B—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MDM2—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—AKT1—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HRAS—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCND1—ocular cancer	0.000344	0.000344	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	0.000341	0.000341	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCND1—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CDKN1A—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HRAS—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCND1—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—AKT1—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—AKT1—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EP300—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	0.000314	0.000314	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EP300—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCND1—ocular cancer	0.00031	0.00031	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—AKT1—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EP300—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EP300—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MYC—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MYC—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TGFB1—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MDM2—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MDM2—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MDM2—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MYC—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TGFB1—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MDM2—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—EP300—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HRAS—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HRAS—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HRAS—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCND1—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCND1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCND1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCND1—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—AKT1—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—AKT1—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EP300—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—AKT1—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HRAS—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—AKT1—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EP300—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EP300—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EP300—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EP300—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HRAS—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HRAS—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—AKT1—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—AKT1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TGFB1—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TGFB1—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TGFB1—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—AKT1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TGFB1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—AKT1—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AKT1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HRAS—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HRAS—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HRAS—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HRAS—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HRAS—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—AKT1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—AKT1—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—AKT1—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—AKT1—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—AKT1—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—AKT1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	0.000125	0.000125	CbGpPWpGaD
